Xiang Zeng; Qing He; Yilan Li; Yong Zhou; Xiaoping Shao; Pei Hu; Jian Liang; Yudan Song; Chao Ma; Lijie Zhang; Limei Sun; Lei Luo; Xiang Zeng; Qing He; Yilan Li; Yong Zhou; Xiaoping Shao; Pei Hu; Jian Liang; Yudan Song; Chao Ma; Lijie Zhang; Limei Sun; Lei Luo

doi:10.46234/ccdcw2024.048

[1]

Wang B, Santoreneos R, Giles L, Afzali HHA, Marshall H. Case fatality rates of invasive meningococcal disease by serogroup and age: A systematic review and meta-analysis. Vaccine 2019;37(21):2768 − 82. https://doi.org/10.1016/j.vaccine.2019.04.020.

[2]

Parikh SR, Campbell H, Bettinger JA, Harrison LH, Marshall HS, Martinon-Torres F, et al. The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination. J Infect 2020;81(4):483 − 98. https://doi.org/10.1016/j.jinf.2020.05.079.

[3]

Li JH, Wu D, Wen N, Zheng H, Shi W, Xu L, et al. Serogroup distribution of meningococcal meningitis in China, 2015–2019. Chin J Vaccines Immun 2020;26(3):241-4. https://d.wanfangdata.com.cn/periodical/zgjhmy202003001. (In Chinese).

[4]

Li JH, Li YX, Wu D, Ning GJ, Shao ZJ, Yin ZD. Epidemiological characteristics of meningococcal meningitis and switching trend of serogroups of Neisseria meningitidis in China, 2006–2014. Chin J Vaccines Immun 2015;21(5):481-5. https://d.wanfangdata.com.cn/periodical/zgjhmy201505001. (In Chinese).

[5]

Zhang LP, Ye XY, Xiong HZ, Huang Y, Ye XF, Zhang QL. Analysis on the first infection case of Neisseria meningitidis Y clonal complex 23 in China. Dis Surveill 2020;35(7):664 − 7. https://doi.org/10.3784/j.issn.1003-9961.2020.07.023.

[6]

Xia X, Fang ML, Qin D, He ZX, Gao LD, Zhan ZF. Etiological characteristics of strains from cases of epidemic cerebrospinal meningitis due to newly isolated Neisseria meningitidis serogroups X and Y in Hunan Province. Pract Prev Med 2021;28(11):1295 − 8. https://doi.org/10.3969/j.issn.1006-3110.2021.11.004.

[7]

Guo LC, Liu XC, Xu QY, Liu YS, Cai Y, Jiang GY, et al. Epidemiological analysis on serogroup Y Neisseria meningitidis firstly isolated from patient in Tianjin. Chin J Prev Med 2016;50(9):825 − 7. https://doi.org/10.3760/cma.j.issn.0253-9624.2016.09.015.

[8]

Bröker M, Jacobsson S, Kuusi M, Pace D, Simões MJ, Skoczynska A, et al. Meningococcal serogroup Y emergence in Europe: update 2011. Hum Vaccines Immunother 2012;8(12):1907 − 11. https://doi.org/10.4161/hv.21794.

[9]

Sharip A, Sorvillo F, Redelings MD, Mascola L, Wise M, Nguyen DM. Population-based analysis of meningococcal disease mortality in the United States: 1990-2002. Pediatr Infect Dis J 2006;25(3):191 − 4. https://doi.org/10.1097/01.inf.0000202065.03366.0c.

[10]

Chang QZ, Tzeng YL, Stephens DS. Meningococcal disease: changes in epidemiology and prevention. Clin Epidemiol 2012;4:237 − 45. https://doi.org/10.2147/CLEP.S28410.